Synlogic Inc Sustainability Reports
Synlogic, Inc. is a biopharmaceutical company that historical focused on advancing synthetic biology-based medicines and rare metabolic disorders, but has wound down major research operations to pivot toward exploring strategic alternatives as a public shell.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493007C6UCNXL4HOI66
FIGI: BBG001T92245
1 reports from 2022 to 2022